The general evaluation of BAYER CROPSCIENCE (IN), a company active in the Speciality Chemicals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date March 22, 2022, the closing price was INR 4,677...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Benchmark (BMK) helps deliver improved healthcare products and services to the Animal Health and Aquaculture industry. Rising demand from clients for its products and services to manage sustainability practice in worldwide production and supply chains underlines BMK’s opportunity for significant organic and external growth. The company held a well-attended Capital Markets Day (CMD) on 27 March, which highlighted its strategic targets for fulfilling its growth potential spanning Advanced Nutri...
Q3FY18 results Bayer reported tepid performance for Q3FY18. Revenues stood at Rs4.7bn, down 25.6% yoy (est: Rs7.2bn). Sales performance was adversely impacted due to erratic rainfall in the month of October which disrupted normal agricultural operations. Gross margins improved by 750bps to 40.7% on lower raw material costs and lower sales returns. Negative operating leverage over fixed overheads led to decline in EBITDA margins. EBITDA declined by 51% to Rs226m (est:Rs720m) , while EBITDA m...
Q2FY18 results Bayer’s Q2FY18 revenues increased by 11.6% yoy to Rs12.3bn (est.Rs11.9bn) despite erratic monsoons and uneven rainfall distribution. Unfavourable product mix led to 200bp dip in Q2FY18 gross margin. However, lower operating expenses (down 20% yoy) led to 183bps improvement in EBITDA margins to 23.3% .EBITDA increased by 21.1% to Rs2.87bn(est.Rs1.8bn) Higher depreciation (up 18% yoy) and interest cost (up 29.4% yoy) led to 19.8% yoy growth in net profit to Rs1.9bn (est.Rs1.82...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.